close

Enter

Log in using OpenID

Cell Therapy Manufacturing Market

embed
Cell therapy is one of the most promising healthcare procedure for restoration of damaged tissue.
Cell Therapy Manufacturing Market - Global
Industry Insights, Trends, Outlook and Opportunity
Analysis, 2018-2026
Cell therapy is one of the most promising healthcare procedure for restoration of damaged
tissue. Cell therapies have huge potential for the wide range of disease treatment including
tissue degradation, immune deficiency, metabolic disorders, and cancer. Cell therapy are
categorized into two type’s allogeneic (cells from third party donor) and autologous (cells from
one’s own body). Cell therapy has gained significant traction in recent past and currently it
under commercial development. Main objective of cell therapy is to re-establish the lost
function of tissues and cells rather than to produce a new organ. Some cell therapies have been
established and permitted for clinical trial. For instance, in 2013 a stage 2 clinical trial was
completed for transplantation of bone marrow derived stem cells in affected knee by rheumatoid
arthritis. The growth of this technique is also increased due to involvement of the government
agencies. For instance, innovate U.K. 2014 report showed that government agreed to fund
US$15.3 million in cell therapy manufacturing market.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1728
Cell Therapy Manufacturing Market Dynamics
Increasing number of surgical procedures performed across the world coupled with increasing
number of trauma and accidents is propelling demand for new medical therapy. For instance,
according to a 2015, World Health Organization (WHO) report, more than 50,000 stem cell
transplants are carried out annually worldwide for various surgeries. Stem cells transplantation
is promising medical therapy for patients with advance stage diseases like Alzheimer’s, arthritis,
autism, blindness, cancer, cerebral palsy, diabetes etc. Key biopharmaceutical companies are
majorly investing in research for cell therapy. For instance, Longeveron LL, a biopharmaceutical
company received a US$ 750,000 grant from the Maryland Technology Development Corporation
(TEDCO) in 2018 for stem cell therapy research. These collaborations and government funding
are boosting growth of the cell therapy manufacturing market. However, the strict regulations,
guidelines, and various health safety concerns over cell therapy treatment are restraining growth
of the cell therapy market.
Cell Therapy Manufacturing Market - Regional Insights
On the basis of the region, the global cell therapy market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant
position in the global cell therapy manufacturing market, owing to large number of surgeries
performed in the region as well as development of technologically advanced products for
therapy. According to the National Health Statistics Report by the Centers for Disease Control &
Prevention (CDC), around 201,748.3 million surgical and non-surgical procedures were
performed in the U.S. in 2011.
Furthermore, Asia Pacific is projected to witness significant growth in the global cell therapy
manufacturing market in the near future. Marginal market share would be grabbed by the local
players entering into market due to less stringent regulatory requirements and growing customer
pool prone to various chronic and infectious disease such as cancer, HIV, hepatitis etc.
Therefore induction of cell therapy can provide better solutions to the patient at the marginally
lower cost.
Report includes chapters which deeply display the following deliverable about industry :
• Cell Therapy Manufacturing Market Research Objective and Assumption
• Cell Therapy Manufacturing Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Cell Therapy Manufacturing Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cell Therapy Manufacturing Market, By Regions
• Cell Therapy Manufacturing Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cell Therapy Manufacturing Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Cell Therapy Manufacturing Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cell Therapy Manufacturing Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Cell Therapy Manufacturing Market - Competitive Insights
The key player operating in the global cell therapy manufacturing market include, Pharmicell,
Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH,
Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris
Therapeutics, Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate,
Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy Catapult EUFETS,
MaSTherCell, PharmaCell, Cognate BioServices and WuXi AppTec. Key players are adoption
growth strategies such as collaborations, introduction of new technologies and devices to
maintain dominant position in the market. For instance, in 2014, ViaCyte, Inc. successfully
implanted VC-01 an embryonic stem cell derived islet for the treatment of type 1 diabetes.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1728
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge302   documents Email
Document
Category
Health and Medicine
Views
2
File Size
110 KB
Tags
Cell Therapy Manufacturing Market, manufacturing
1/--pages
Report inappropriate content